2 Growth Stocks to Buy Hand Over Fist in April

Earnings season, which is fast approaching, is often somewhat volatile for the stock market. Companies that overdeliver or fail to deliver can see their share prices move significantly overnight.

However, long-term investors know that one quarterly report rarely changes the fundamental investment thesis of a corporation. It's nice to have money invested in excellent equities that should perform well no matter what happens in the next few weeks.

Let's consider two growth stocks that fit the bill: Eli Lilly (NYSE: LLY) and (NASDAQ: DXCM).

Source Fool.com

Dexcom Inc. Aktie

Nur eine marginale Kursänderung bei Dexcom Inc. seit gestern, um 0,05 %.
Klare Kaufempfehlung: Dexcom Inc. erhält nur Buy-Einschätzungen.
Eine Steigerung von über 50% ist für Dexcom Inc. möglich, angesichts eines Kursziels von 121 € gegenüber 63.19 €.

Like: 0

LLY

Teilen